On November 7, 2014, the company announced that it has extended its plan duration till November 6, 2015.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
10,320 KRW | +0.98% | -0.77% | -12.32% |
2023 | Jeil Pharma Holdings Inc Reports Earnings Results for the First Quarter Ended March 31, 2023 | CI |
2022 | Jeil Pharma Holdings Inc's Equity Buyback Plan Extended till October 2, 2042. | CI |
1st Jan change | Capi. | |
---|---|---|
-12.32% | 113M | |
+15.37% | 41.97B | |
+22.56% | 22.34B | |
+14.89% | 15.25B | |
+16.53% | 14B | |
+49.78% | 12.06B | |
-10.77% | 6.8B | |
-0.05% | 6.79B | |
-8.87% | 5.73B | |
+14.18% | 5.49B |
- Stock Market
- Equities
- A002620 Stock
- News Jeil Pharma Holdings Inc
- Jeil Pharmaceutical Co., Ltd's Equity Buyback Plan Extended till November 7, 2013.